In this study, we describe the development of a novel tissue marker that can be injected from within the digestive tract by using an endoscopic instrument, and visualized using near-infrared (NIR) fluorescence imaging. The marker was prepared in three steps, (i) mixing NIR-fluorescent indocyanine green (ICG) with giant vesicles (GVs) of lecithin, (ii) suspending the ICG-containing giant vesicles (ICG-GV) in an oil phase dissolving polyglycerol-polyricinoleate (PGPR), and (iii) centrifugation of the suspension layered on a buffered solution to obtain a giant polymer vesicle (polymerasome) containing ICG-GV. We injected the tissue marker into the inner gastric surface of an anesthetized pig using an endoscopic syringe, and observed the injection site using a fluorescence laparoscopic camera. The diameter of the spot blur was approximately 2 cm over a 5-h period, demonstrating the utility of this procedure as a tissue marker for tumor marking, and suggesting its potential for assisting navigation during surgical procedures.
Introduction
Recent advances of surgical techniques in laparoscopic surgery have occurred and developed totally for laparoscopic operations without any extracorporeal procedures for the treatment of malignant gastrointestinal disease. [1] [2] [3] [4] Although these operations have been shown to have various clinical advantages over laparoscope-assisted operations (including any extracorporeal procedures), unexpected matters to be solved have been arising. The major target of such laparoscopic surgeries would be early-stage cancers of the alimentary tract. These neoplasms arise from mucosa (lumen side) of the gut; therefore, the precise location of the lesion and the extent of resection is usually determined by the surgeons' palpation during surgery. However, the palpation of the target organ is no more available during totally laparoscopic surgery, and thus such a confirmation procedure must be performed only by inspection under laparoscopic guidance. Early gastrointestinal cancers invade no more deeply than the submucosa, and usually do not cause any alteration to the serosal (outer) surface of the lesion. Consequently, it remains considerably difficult to secure the required minimum margins from tumors upon organ resection. Although various techniques using preoperative or intraoperative gastrointestinal endoscopy to assist intraoperative localization of tumors had been proposed, [5] [6] [7] [8] [9] [10] [11] none of these has been a conclusive solution. Meanwhile, near-infrared (NIR) fluorescent molecules, such as indocyanine green (ICG), have drawn much attention as a navigation surgery probe, because the NIR light has high permeability in the organ tissues, and they can be excited and detected from outside of the organ tissue with a fluorescence CCD camera. [12] [13] [14] [15] Furthermore, ICG has been approved by the Food and Drug Administration in the United States. 16 The only problem for using this fluorescent probes for the tissue marker still remains in terms of blur 17, 18 and bleaching effects. 19, 20 The purpose of this study was to develop a tissue marker for identifying the location of digestive-tract tumors using NIR-fluorescent laparoscopy. The tissue marker was required to fulfill three criteria: (i) maintaining the stability of ICG in vivo, (ii) protecting the probe against the immune response in the digestive tracts, and (iii) localizing the probe at the site of injection through an endoscopic syringe. In order to insulate the NIR fluorescent probe against a host immune response, we prepared ICG-containing giant vesicles (GVs), which are closed bilayer lipid membranes with diameters larger than 1 μm. To prevent any separation and diffusion of the ICG-containing GVs (ICG-GVs), we effected coagulation of the ICG-GVs. There have been previous reports concerning the coagulation of vesicles via membrane-anchored protein interactions, 21, 22 molecular cognition 23, 24 or multivalent cation-anion interactions. 25 The narrow internal diameter of the endoscopic syringe (0.6 mm), however, can be blocked by an excessively viscous solution. Moreover, fluctuations in the ionic strength of the tissue often result in difficulty during tissue-marker injection. Accordingly, to encapsulate the GVs, we adopted a polymerbased micrometer-capsule. To facilitate encapsulation of the micrometer-sized colloidal particles, we employed a water-inoil emulsion centrifugation method [26] [27] [28] using the biodegradable amphiphilic copolymer polyglycerol-polyricinoleate (PGPR), which is typically used as a food emulsifier. 29 Dissolving PGPR in a biodegradable oil, such as squalene, followed by centrifugation, forces the water-in-oil emulsion droplets surrounded by the copolymer monolayer across the water-oil interface monolayer to generate a closed bilayer membrane of the copolymer, or polymerasome. When the ICG-GVs are encapsulated in the water-in-oil (W/O) emulsion of squalene dissolving PGPR, the PGPR polymerasome containing the ICGGVs is produced in the abovementioned process.
Experimental

Materials
Indocyanine green (Diagnogreen ® ) was purchased from Daiichi-Sankyo Co., Ltd. (Tokyo, Japan).
Egg yolk phosphatidylcholine (EYPC, average Mw = 770), squalene, D-glucose, sucrose, and rhodamine 6G were supplied by Kanto Chemical Co., Inc. (Tokyo, Japan). Polyglycerol-polyricinoleate (Poem ® PR-100) was provided by Riken Vitamin Co., Ltd. (Tokyo, Japan). Physiological saline was purchased from Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan). Water was distilled, and then subjected to ion exchange with a Milli-Q water system (Millipore, MA).
Preparation of tissue marker
The ICG-GV was formed by dispersing ICG and EYPC in a Tris-HCl buffered solution (50 mM, pH 7.8) containing 1 M sucrose in a 1.5-mL plastic tube with stirring using a vortex mixer for 5 min. After ICG-GV dispersion (0.5 mL) was suspended into the oil phase (3.5 mL) of squalene dissolving PGPR (15 w/w%) by agitation using a vortex mixer for 5 min, the resulting W/O emulsion was layered on a buffered solution (7.0 mL) of 50 mM Tris-HCl (pH 7.8) and 1 M D-glucose in a 15-mL plastic tube. The W/O emulsion was centrifuged at 2250g (3500 rpm) at room temperature (22 -24 C) for 30 min (H-103N; KOKUSAN, Tokyo, Japan). The precipitated PGPR polymerasomes, containing ICG-GVs, were collected using a micropipette after the oil phase and the supernatant were carefully removed by aspiration using a capillary connected to a peristaltic pump (MP-3N; EYELA, Tokyo, Japan).
Microscopy for observing tissue marker
Phase contrast and NIR fluorescence micrographs of the tissue marker were acquired with an Olympus BX51 microscope (Tokyo, Japan) equipped with a xenon lamp and a filter unit (λex, 738 -795 nm; λem, 814 -862 nm) for fluorescence microscopy. The micrographs were digitally recorded using a CCD camera (Lumina Vision, Mitani Co., Tokyo, Japan). To observe the PGPR polymerasome, we stained the oil phase with rhodamine 6G (1 μM), and observed the prepared tissue marker by differential interference contrast and fluorescence microscopy with an Olympus IX70 microscope (Japan) equipped with a halogen lamp and a filter unit (λex, 520 -550 nm; λem, >580 nm).
NIR fluorescence imaging and fluorescence spectroscopy
In order to obtain NIR fluorescence images of the tissue marker both in vitro and ex vivo, a NIR light-emitting diode (LED) light (IFL-50/50IR-780; IMAC, Japan) with a short-pass filter (<780 nm) and a NIR charge couple device (CCD) camera (WAT-902H; WATEC, Japan) with a long-pass filter (>810 nm) were used. The LED light and the CCD camera were positioned 200 mm from the sample. An intensity profile of the fluorescence images was generated using image analysis software (Image J; NIH, USA). The fluorescence spectra of the tissue marker and the ICG aqueous solution were obtained by FP-6600 (JASCO, Japan).
Viscosity measurement
In order to measure the elastic viscosity of the tissue marker, a cone-plate type rheometer (Rheo Stress RS100; Haake, Karlsruhe, Germany) was used under 25 and 37 C. Since the tissue marker exhibited a Newtonian fluidic behavior under a shear rate of 500 -1000 s -1 , we were able to measure the viscosity of the tissue marker.
Ex vivo and in vivo experiments using pigs
The animal experiment protocol was reviewed and approved by the Institutional Animal Care and Use Committee of Animal Experimentation, Chiba University.
Prior to the in vivo experiment, the tissue marker was observed after injection into pieces of tissue excised from the stomach of a 6-month-old pig (Tokyo Shibaura Zouki, Co., Tokyo, Japan). The stomach tissue was rinsed several times with water immediately after extraction from the body and stored in saline on ice for no more than 3 h. For the in vivo experiment, pigs were fasted for 48 h prior to anesthetization for 4 h. A cardiopulmonary function apparatus was attached and carbon dioxide gas was loaded into the stomach, after which an endoscope (length, 1.65 m; XL-4400; Olympus, Japan) was inserted with a syringe needle (i.d., 0.6 mm; TOP; Olympus, Japan), and 300 μL of the tissue marker was injected into the submucosal surface of the stomach. The injection was monitored and navigated by video capture of the endoscope. NIR-fluorescence laparoscopy was performed using a laparoscope (WA53005A; Olympus, Japan) equipped with an excitation filter (<800 nm; Newport, Tokyo, Japan) and a detection filter (>810 nm; Asahi Spectra Co., Ltd., Tokyo, Japan), and recorded by a highly sensitive monochrome CCD camera (Flovel, Tokyo, Japan). Figure 1a shows phase-contrast and NIR-fluorescence microscopy images of the tissue marker. The tissue marker contains multiple compartments (diameter range of 10 -70 μm) encapsulating the GVs with the diameters of 7 ± 5 μm (average ± standard deviation). Besides, fluorescence microscopy using the filter of NIR-fluorescence showed that the NIR fluorescence from encapsulated GVs was observed.
Results and Discussion
The diameter of the polymerasome of the tissue marker was in the range of 40 -200 μm. When we mixed rhodamine 6G in the oil phase and prepared the tissue marker, multiple compartment walls were observed under a fluorescence microscope (Fig. 1b) . These results indicate that, as intended, ICG was incorporated into EYPC GVs, and ICG-GVs were encapsulated in the PGPR polymerasome (Fig. 2) .
Reducing the amount of PGPR dissolved in squalene failed to generate the tissue marker, but resulted in the appearance of naked ICG-GVs. Note that the tissue marker was composed of the polymerasome with the multiple compartments instead of a single compartment. In the case of the water-in-oil emulsion centrifugation method using oil-phase dissolving phospholipids or single-chain surfactants, vesicles formed by the transfer of water droplets through the water-emulsion interface have a spherical shape with a single compartment. [26] [27] [28] 30 This tissue marker morphology is presumably caused by the coagulation of water droplets at the interface before transfer and stabilization of the hemi-fused membrane, due to the hydrophobic interaction of PGPR monolayer membranes.
To optimize the NIR-fluorescence intensity of the tissue marker, we prepared tissue markers with different amounts of ICG and EYPC, and observed them using the NIR-fluorescence CCD camera. Figure 3a shows NIR fluorescence images of the tissue marker dispersion prepared with ICG of 3.2 × 10 -4 -3.2 × 10 -1 mM and EYPC of 40 mM. The most brilliant fluorescence image was obtained from the tissue marker containing ICG of 3.2 × 10 -2 mM. When we increased the amount of EYPC from 0 to 40 mM with an ICG concentration of 3.2 × 10 -2 mM, the fluorescence intensity increased as the amount of lecithin increased, and was saturated at 30 mM (Fig. 3b) . The increase in the fluorescence intensity of the tissue marker was also validated by using a fluorescence spectrometer (Fig. 3c) . Accordingly, we deduced that the molar fraction of ICG to EYPC is optimal at around 0.1 mol%, indicating that ICG is usable as well as a conventional fluorescent dye in the visible-light region of the spectrum. 31 While a high viscosity of the tissue marker dispersion is desirable for suppressing the blur in the submucosa, it is not optimal for rapid injection, due to the pressure release in the long (length, 1.65 m) and narrow (i.d., 0.6 mm) endoscope tube. We found that the viscosity of the tissue marker dispersion was 2.43 ± 0.28 cP and 3.77 ± 0.75 cP at 25 C (room temperature) and 37 C (physiological temperature), respectively. Since the density of the tissue marker dispersion was 1.002 g/cm 3 , the kinetic viscosity was calculated to be 2.4 cSt (25 C) and 3.7 cSt (37 C), which are comparable to those of fluidic aqueous solutions of dyes or alcohols. 32 These results indicate that the tissue marker is compatible with rapid syringe injection during surgery. According to these results, we determined the experimental parameters for preparing the tissue marker as follows: ICG of 3.2 × 10 -2 mM and EYPC of 40 mM for ICG-GV and PGPR 15 w/w% for the polymerasome.
Next, we observed the tissue marker using the NIRfluorescence CCD camera during injection into the submucosa of an excised pig stomach. We injected the tissue marker dispersion into the submucosa on the inner surface of the stomach, and captured the NIR-fluorescence image from the outer surface of the stomach. After observation, the stomach was stored in saline for 22 h, before another NIR-fluorescence image was captured (Fig. 4) . The line profiles of the fluorescence intensity of the bright spot were analyzed by Image J. We found that the NIR fluorescence of the tissue marker was clearly detected, and was not affected by storage for 22 h. Moreover, we found that the diameter of the spot size was a function of the injection volume of the tissue marker dispersion (100 μL injection volume; spot size, 6 ± 5 mm; 300 μL injection volume; spot size, 10 ± 5 mm; and 500 μL injection volume; spot size, 12 ± 8 mm). These results indicate that the submucosa is a highly viscous tissue and that the stomach surface skin is elastic, resulting in the accumulation of the injected tissue marker dispersion as an approximately hemispherical shape. Next, we performed in vivo laparoscopy of an anesthetized pig in which the tissue marker dispersion was injected through a syringe installed on the endoscope (Fig. 5a ). The separation of the injection sites (2 cm) and the volume of the tissue marker dispersion (300 μL) were determined based on the visibility of the image on the CCD camera (Fig. 5b ). Since the pig had been fasted for 2 days, the surface and submucosa of the stomach were sufficiently clear to permit observation of the tissue marker through the endoscope camera. The laparoscope was then inserted into the pig and observed the NIR fluorescent image of the tissue marker. The pig was left under anesthesia for 5 h, after which the tissue marker was again observed using the laparoscope. Figure 5c shows bright-field and fluorescence images of the tissue marker, indicating suppression of the blurring of the tissue marker to around 2 cm in diameter. The pig was then sutured, and the laparoscope was re-inserted 24 h later after being convinced that the fluorescence spots on the pig stomach remained the blurring size. The difference in the fluorescence intensity of the spots shown in Fig. 5c is due to changing the distance of the pig stomach and the camera of the laparoscope because the insertion and fixing of the laparoscope in vivo was practically difficult; also the pig stomach could move even though the pig was under anesthesia. When an aqueous solution of ICG (3.2 × 10 -2 mM) was used as a reference experiment in the same procedure, we observed greater blurring of ICG than that obtained with our tissue marker, and were unable to determine the injection sites by NIR-fluorescence laparoscopy 5 h after injection. These results indicate that ICG retained its fluorescence intensity, and that the PGPR polymerasome containing the ICG-GV was tolerant of the physiological milieu of the submucosa of the pig stomach. It should be noted that since the tissue marker would be used only for marking the tumor, and would be surgically extracted along the tumor, the long-term toxicity of the tissue marker to patients is not of significant concern.
Conclusions
Here, we describe the development of a novel NIR-fluorescent, GV-, and polymerasome-based tissue marker applicable to both endoscopic and laparoscopic surgical navigation. Bleaching of the NIR-fluorescent ICG was avoided by incorporation into the GV, and the in vivo blur of the tissue marker was minimized. Moreover, the site of the injection of tissue marker in the submucosa of the pig stomach was successfully observed by an NIR-fluorescence laparoscopic camera, and was found to retain both its fluorescence and spot size for at least 5 h.
The characteristics of the current tissue marker are unique in several respects. Firstly, since it is composed of only organic materials, there is no danger of electric interference with electrical surgery implements, such as scalpels. Second, since most of the components of the marker are derived from food or food additives, and ICG has been previously used in clinical practice, the toxicity of the tissue marker is expected to be low, especially in the digestive system. Third, when each contrast agent is incorporated in the polymerasome and GV, the tissue marker can be applied to a multi-modal imaging marker, such as magnetic resonance imaging, X-ray computed tomography or diagnostic ultrasound imaging system. Fourth, since the tissue marker has a hierarchical structure of a lipid capsule, drugs can be encapsulated on the interior of the tissue marker. In addition, ICG is an optical sensitizer in photodynamic therapy and photothermal therapy. 33, 34 This application is directly linked to the drug delivery system against tumors. We anticipate that the novel tissue marker that we have described has potential application in the development of high-precision navigational techniques for surgery of the gastrointestinal tract.
